Chemomab Therapeutics (CMMB) Share-based Compensation (QoQ) (2019 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -34.59% |
| Dec 31, 2022 | -11.48% |
| Sep 30, 2022 | 9.86% |
| Jun 30, 2022 | -12.93% |
| Mar 31, 2022 | -13.29% |
| Dec 31, 2021 | 128.57% |
| Sep 30, 2021 | -16.32% |
| Jun 30, 2021 | 1,125.58% |
| Mar 31, 2021 | 30.30% |
| Dec 31, 2020 | 109.24% |
| Sep 30, 2020 | -761.11% |
| Jun 30, 2020 | 17.39% |
| Mar 31, 2020 | -48.31% |
| Dec 31, 2019 | -42.21% |
| Sep 30, 2019 | -31.86% |
| Jun 30, 2019 | -40.53% |